Here, we establish an in vitro liver disease model of liver organoids and hepatocytes developed from iPSCs of DGUOK mutant patients, along with associated controls and isogenic cell lines corrected by the CRISPR/Cas9 system. This evidence concerns the gene DGUOK and liver disorder.